Detalles de la búsqueda
1.
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group.
Lancet Oncol
; 24(2): e86-e95, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725153
2.
EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors.
Oncologist
; 25(6): e976-e981, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154610
3.
Bridging the gap: a review of dose investigations in paediatric investigation plans.
Br J Clin Pharmacol
; 78(4): 898-907, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24720849
4.
How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma.
Eur J Cancer
; 202: 114003, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38479120
5.
Report of the European Medicines Agency Conference on RNA-Based Medicines.
Nucleic Acid Ther
; 34(1): 4-11, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38174996
6.
Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators.
Front Med (Lausanne)
; 10: 1181702, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37324145
7.
The Impact of COVID-19 on the Initiation of Clinical Trials in Europe and the United States.
Clin Pharmacol Ther
; 111(5): 1093-1102, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090044
8.
Health horizons: Future trends and technologies from the European Medicines Agency's horizon scanning collaborations.
Front Med (Lausanne)
; 9: 1064003, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36569125
9.
Role of modeling and simulation in pediatric investigation plans.
Paediatr Anaesth
; 21(3): 214-21, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21244569
10.
Can a Multistakeholder Prioritization Structure Support Regulatory Decision Making? A Review of Pediatric Oncology Strategy Forums Reflecting on Challenges and Opportunities of this Concept.
Clin Pharmacol Ther
; 108(3): 553-556, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32559312
11.
The European Innovation Network as a hub for medicines innovation in Europe.
Nat Rev Drug Discov
; 23(6): 405-406, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38467771
12.
Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
Eur J Cancer
; 44(2): 257-68, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17981026
13.
Oculocutaneous albinism accompanied by minor morphologic stigmata and reduced number and function of NK cells. A new variant of NK cell defect?
Eur J Pediatr
; 167(10): 1175-82, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18202852
14.
Artificial intelligence in European medicines regulation.
Nat Rev Drug Discov
; 22(2): 81-82, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36411368
15.
The opportunity for greater patient and public involvement and engagement in drug development and regulation.
Nat Rev Drug Discov
; 22(5): 337-338, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36854837
16.
Therapeutic genome editing: regulatory horizons.
Nat Rev Drug Discov
; 21(1): 1-2, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34326503
17.
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project.
Expert Opin Drug Discov
; 12(8): 801-811, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28604107
18.
Preamble may not improve consent and assent process.
Pediatr Blood Cancer
; 56(2): 327; author reply 328, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21157901
19.
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a "European Pediatric Oncology Off-patents Medicines Consortium" trial.
Cancer Chemother Pharmacol
; 78(6): 1175-1184, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27770238
20.
Implementation of mechanism of action biology-driven early drug development for children with cancer.
Eur J Cancer
; 62: 124-31, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27258969